Skip to main content
Top
Published in: Critical Care 6/2010

Open Access 01-12-2010 | Research

Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study

Authors: Stephen J Chapman, Chiea C Khor, Fredrik O Vannberg, Anna Rautanen, Andrew Walley, Shelley Segal, Catrin E Moore, Robert JO Davies, Nicholas P Day, Norbert Peshu, Derrick W Crook, James A Berkley, Thomas N Williams, J Anthony Scott, Adrian VS Hill

Published in: Critical Care | Issue 6/2010

Login to get access

Abstract

Introduction

Streptococcus pneumoniae remains a major global health problem and a leading cause of death in children worldwide. The factors that influence development of pneumococcal sepsis remain poorly understood, although increasing evidence points towards a role for genetic variation in the host's immune response. Recent insights from the study of animal models, rare human primary immunodeficiency states, and population-based genetic epidemiology have focused attention on the role of the proinflammatory transcription factor NF-κB in pneumococcal disease pathogenesis. The possible role of genetic variation in the atypical NF-κB inhibitor IκB-R, encoded by NFKBIL2, in susceptibility to invasive pneumococcal disease has not, to our knowledge, previously been reported upon.

Methods

An association study was performed examining the frequencies of nine common NFKBIL2 polymorphisms in two invasive pneumococcal disease case-control groups: European individuals from hospitals in Oxfordshire, UK (275 patients and 733 controls), and African individuals from Kilifi District Hospital, Kenya (687 patients with bacteraemia, of which 173 patients had pneumococcal disease, together with 550 controls).

Results

Five polymorphisms significantly associated with invasive pneumococcal disease susceptibility in the European study, of which two polymorphisms also associated with disease in African individuals. Heterozygosity at these loci was associated with protection from invasive pneumococcal disease (rs760477, Mantel-Haenszel 2 × 2 χ2 = 11.797, P = 0.0006, odds ratio = 0.67, 95% confidence interval = 0.53 to 0.84; rs4925858, Mantel-Haenszel 2 × 2 χ2 = 9.104, P = 0.003, odds ratio = 0.70, 95% confidence interval = 0.55 to 0.88). Linkage disequilibrium was more extensive in European individuals than in Kenyans.

Conclusions

Common NFKBIL2 polymorphisms are associated with susceptibility to invasive pneumococcal disease in European and African populations. These findings further highlight the importance of control of NF-κB in host defence against pneumococcal disease.
Appendix
Available only for authorised users
Literature
2.
go back to reference Wardlaw T, Salama P, Johansson EW, Mason E: Pneumonia: the leading killer of children. Lancet. 2006, 368: 1048-1050. 10.1016/S0140-6736(06)69334-3.CrossRefPubMed Wardlaw T, Salama P, Johansson EW, Mason E: Pneumonia: the leading killer of children. Lancet. 2006, 368: 1048-1050. 10.1016/S0140-6736(06)69334-3.CrossRefPubMed
3.
go back to reference World Health Organisation: Pneumococcal vaccines. Wkly Epidemiol Record. 2003, 78: 110-118. World Health Organisation: Pneumococcal vaccines. Wkly Epidemiol Record. 2003, 78: 110-118.
4.
go back to reference Bogaert D, de Groot R, Hermans PWM: Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004, 4: 144-154. 10.1016/S1473-3099(04)00938-7.CrossRefPubMed Bogaert D, de Groot R, Hermans PWM: Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004, 4: 144-154. 10.1016/S1473-3099(04)00938-7.CrossRefPubMed
5.
go back to reference Brouwer MC, de Gans J, Heckenberg SG, Zwinderman AH, van der Poll T, van de Beek D: Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2009, 9: 31-44. 10.1016/S1473-3099(08)70261-5.CrossRefPubMed Brouwer MC, de Gans J, Heckenberg SG, Zwinderman AH, van der Poll T, van de Beek D: Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2009, 9: 31-44. 10.1016/S1473-3099(08)70261-5.CrossRefPubMed
6.
go back to reference Amory-Rivier CF, Mohler J, Bedos JP, Azoulay-Dupuis E, Henin D, Muffat-Joly M, Carbon C, Moine P: Nuclear factor-κB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection. Crit Care Med. 2000, 28: 3249-3256. 10.1097/00003246-200009000-00021.CrossRefPubMed Amory-Rivier CF, Mohler J, Bedos JP, Azoulay-Dupuis E, Henin D, Muffat-Joly M, Carbon C, Moine P: Nuclear factor-κB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection. Crit Care Med. 2000, 28: 3249-3256. 10.1097/00003246-200009000-00021.CrossRefPubMed
7.
go back to reference Jones MR, Simms BT, Lupa MM, Kogan MS, Mizgerd JP: Lung NF-κB activation and neutrophils recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J Immunol. 2005, 175: 7530-7535.PubMedCentralCrossRefPubMed Jones MR, Simms BT, Lupa MM, Kogan MS, Mizgerd JP: Lung NF-κB activation and neutrophils recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J Immunol. 2005, 175: 7530-7535.PubMedCentralCrossRefPubMed
8.
go back to reference Puel A, Picard C, Ku CL, Smahi A, Casanova JL: Inherited disorders of NF-κB-mediated immunity in man. Curr Opin Immunol. 2004, 16: 34-41. 10.1016/j.coi.2003.11.013.CrossRefPubMed Puel A, Picard C, Ku CL, Smahi A, Casanova JL: Inherited disorders of NF-κB-mediated immunity in man. Curr Opin Immunol. 2004, 16: 34-41. 10.1016/j.coi.2003.11.013.CrossRefPubMed
9.
go back to reference Chapman SJ, Khor CC, Vannberg FO, Frodsham A, Walley A, Maskell NA, Davies CWH, Segal S, Moore CE, Gillespie SH, Denny P, Day NP, Crook DW, Davies RJO, Hill AVS: IκB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med. 2007, 176: 181-187. 10.1164/rccm.200702-169OC.CrossRefPubMed Chapman SJ, Khor CC, Vannberg FO, Frodsham A, Walley A, Maskell NA, Davies CWH, Segal S, Moore CE, Gillespie SH, Denny P, Day NP, Crook DW, Davies RJO, Hill AVS: IκB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med. 2007, 176: 181-187. 10.1164/rccm.200702-169OC.CrossRefPubMed
10.
go back to reference Chapman SJ, Khor CC, Vannberg FO, Rautanen A, Segal S, Moore CE, Davies RJO, Day NP, Peshu N, Crook DW, Berkley JA, Williams TN, Scott JA, Hill AVS: NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes Immunity. 2009, 11: 319-325. 10.1038/gene.2009.76.PubMedCentralCrossRefPubMed Chapman SJ, Khor CC, Vannberg FO, Rautanen A, Segal S, Moore CE, Davies RJO, Day NP, Peshu N, Crook DW, Berkley JA, Williams TN, Scott JA, Hill AVS: NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes Immunity. 2009, 11: 319-325. 10.1038/gene.2009.76.PubMedCentralCrossRefPubMed
11.
go back to reference Ghosh S, May MJ, Kopp EB: NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu Rev Immunol. 1998, 16: 225-260. 10.1146/annurev.immunol.16.1.225.CrossRefPubMed Ghosh S, May MJ, Kopp EB: NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu Rev Immunol. 1998, 16: 225-260. 10.1146/annurev.immunol.16.1.225.CrossRefPubMed
12.
go back to reference Baldwin AS: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996, 14: 649-681. 10.1146/annurev.immunol.14.1.649.CrossRefPubMed Baldwin AS: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996, 14: 649-681. 10.1146/annurev.immunol.14.1.649.CrossRefPubMed
13.
go back to reference Siebenlist U, Brown K, Claudio E: Control of lymphocyte development by nuclear factor-κB. Nat Rev Immunol. 2005, 5: 435-445. 10.1038/nri1629.CrossRefPubMed Siebenlist U, Brown K, Claudio E: Control of lymphocyte development by nuclear factor-κB. Nat Rev Immunol. 2005, 5: 435-445. 10.1038/nri1629.CrossRefPubMed
14.
go back to reference Ray P, Zhang DH, Elias JA, Ray A: Cloning of a differentially expressed IκB-related protein. J Biol Chem. 1995, 270: 10680-10685. 10.1074/jbc.270.18.10680.CrossRefPubMed Ray P, Zhang DH, Elias JA, Ray A: Cloning of a differentially expressed IκB-related protein. J Biol Chem. 1995, 270: 10680-10685. 10.1074/jbc.270.18.10680.CrossRefPubMed
15.
go back to reference Norman DAM, Barton PJR: Isolation, sequence, and chromosomal localisation of the human IκBR gene (NFKBIL2). Ann Hum Genet. 2000, 64: 15-23. 10.1046/j.1469-1809.2000.6410015.x.CrossRefPubMed Norman DAM, Barton PJR: Isolation, sequence, and chromosomal localisation of the human IκBR gene (NFKBIL2). Ann Hum Genet. 2000, 64: 15-23. 10.1046/j.1469-1809.2000.6410015.x.CrossRefPubMed
16.
go back to reference Ray P, Yang L, Zhang DH, Ghosh SK, Ray A: Selective up-regulation of cytokine-induced RANTES gene expression in lung epithelial cells by overexpression of IκBR. J Biol Chem. 1997, 272: 20191-20197. 10.1074/jbc.272.32.20191.CrossRefPubMed Ray P, Yang L, Zhang DH, Ghosh SK, Ray A: Selective up-regulation of cytokine-induced RANTES gene expression in lung epithelial cells by overexpression of IκBR. J Biol Chem. 1997, 272: 20191-20197. 10.1074/jbc.272.32.20191.CrossRefPubMed
17.
go back to reference Roy S, Knox K, Segal S, Griffiths D, Moore CE, Welsh KI, Smarason A, Day NP, McPheat WL, Crook DW, Hill AV, Oxford Pneumococcal Surveillance Group: MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet. 2002, 359: 1569-1573. 10.1016/S0140-6736(02)08516-1.CrossRefPubMed Roy S, Knox K, Segal S, Griffiths D, Moore CE, Welsh KI, Smarason A, Day NP, McPheat WL, Crook DW, Hill AV, Oxford Pneumococcal Surveillance Group: MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet. 2002, 359: 1569-1573. 10.1016/S0140-6736(02)08516-1.CrossRefPubMed
18.
go back to reference Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007, 447: 661-678. 10.1038/nature05911.CrossRef Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007, 447: 661-678. 10.1038/nature05911.CrossRef
19.
go back to reference Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, Ngetsa C, Slack MP, Njenga S, Hart CA, Maitland K, English M, Marsh K, Scott JA: Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005, 352: 39-47. 10.1056/NEJMoa040275.CrossRefPubMed Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, Ngetsa C, Slack MP, Njenga S, Hart CA, Maitland K, English M, Marsh K, Scott JA: Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005, 352: 39-47. 10.1056/NEJMoa040275.CrossRefPubMed
22.
go back to reference Jurinke C, van den Boom D, Cantor CR, Koster H: The use of MassARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol. 2002, 77: 57-74.PubMed Jurinke C, van den Boom D, Cantor CR, Koster H: The use of MassARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol. 2002, 77: 57-74.PubMed
23.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21: 263-265. 10.1093/bioinformatics/bth457.CrossRefPubMed
24.
go back to reference Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science. 2002, 296: 2225-2229. 10.1126/science.1069424.CrossRefPubMed Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science. 2002, 296: 2225-2229. 10.1126/science.1069424.CrossRefPubMed
25.
go back to reference NCI-NHGRI Working Group on Replication in Association Studies: Replicating genotype-phenotype associations. Nature. 2007, 447: 655-660. 10.1038/447655a.CrossRef NCI-NHGRI Working Group on Replication in Association Studies: Replicating genotype-phenotype associations. Nature. 2007, 447: 655-660. 10.1038/447655a.CrossRef
26.
go back to reference Bernatoniene J, Zhang Q, Dogan S, Mitchell TJ, Paton JC, Finn A: Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-κB, and mitogen-activated protein kinases. J Infect Dis. 2008, 198: 1823-1833. 10.1086/593177.CrossRefPubMed Bernatoniene J, Zhang Q, Dogan S, Mitchell TJ, Paton JC, Finn A: Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-κB, and mitogen-activated protein kinases. J Infect Dis. 2008, 198: 1823-1833. 10.1086/593177.CrossRefPubMed
27.
go back to reference Palaniappan R, Singh S, Singh UP, Singh R, Ades EW, Briles DE, Hollingshead SK, Royal W, Sampson JS, Stiles JK, Taub DD, Lillard JW: CCL5 modulates pneumococcal immunity and carriage. J Immunol. 2006, 176: 2346-2356.CrossRefPubMed Palaniappan R, Singh S, Singh UP, Singh R, Ades EW, Briles DE, Hollingshead SK, Royal W, Sampson JS, Stiles JK, Taub DD, Lillard JW: CCL5 modulates pneumococcal immunity and carriage. J Immunol. 2006, 176: 2346-2356.CrossRefPubMed
28.
go back to reference Dean M, Carrington M, O'Brien SJ: Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet. 2002, 3: 263-292. 10.1146/annurev.genom.3.022502.103149.CrossRefPubMed Dean M, Carrington M, O'Brien SJ: Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet. 2002, 3: 263-292. 10.1146/annurev.genom.3.022502.103149.CrossRefPubMed
29.
go back to reference Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, Uphill JB, Goldstein D, Alpers M, Fisher EM, Collinge J: Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science. 2003, 300: 640-643. 10.1126/science.1083320.CrossRefPubMed Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, Uphill JB, Goldstein D, Alpers M, Fisher EM, Collinge J: Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science. 2003, 300: 640-643. 10.1126/science.1083320.CrossRefPubMed
30.
go back to reference Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ: HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science. 1999, 283: 1748-1752. 10.1126/science.283.5408.1748.CrossRefPubMed Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ: HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science. 1999, 283: 1748-1752. 10.1126/science.283.5408.1748.CrossRefPubMed
31.
go back to reference Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Peshu N, Williams TN, Davies RJO, Kwiatkowski DP, Day NP, Crook DW, Marsh K, Berkley JA, O'Neill LAJ, Hill AVS: A functional variant in MAL/TIRAP and protection against invasive pneumococcal disease, bacteraemia, malaria and tuberculosis. Nat Genet. 2007, 39: 523-528. 10.1038/ng1976.PubMedCentralCrossRefPubMed Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S, Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Peshu N, Williams TN, Davies RJO, Kwiatkowski DP, Day NP, Crook DW, Marsh K, Berkley JA, O'Neill LAJ, Hill AVS: A functional variant in MAL/TIRAP and protection against invasive pneumococcal disease, bacteraemia, malaria and tuberculosis. Nat Genet. 2007, 39: 523-528. 10.1038/ng1976.PubMedCentralCrossRefPubMed
32.
go back to reference Acevedo-Whitehouse K, Vicente J, Gortazar C, Hofle U, Fernandez-de-Mera IG, Amos W: Genetic resistance to bovine tuberculosis in the Iberian wild boar. Mol Ecol. 2005, 14: 3209-3217. 10.1111/j.1365-294X.2005.02656.x.CrossRefPubMed Acevedo-Whitehouse K, Vicente J, Gortazar C, Hofle U, Fernandez-de-Mera IG, Amos W: Genetic resistance to bovine tuberculosis in the Iberian wild boar. Mol Ecol. 2005, 14: 3209-3217. 10.1111/j.1365-294X.2005.02656.x.CrossRefPubMed
33.
go back to reference Karin M, Yamamoto Y, Wang QM: The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov. 2004, 3: 17-26. 10.1038/nrd1279.CrossRefPubMed Karin M, Yamamoto Y, Wang QM: The IKK NF-κB system: a treasure trove for drug development. Nat Rev Drug Discov. 2004, 3: 17-26. 10.1038/nrd1279.CrossRefPubMed
34.
go back to reference Abraham E: Alterations in cell signaling in sepsis. Clin Infect Dis. 2005, 41: S459-S64. 10.1086/431997.CrossRefPubMed Abraham E: Alterations in cell signaling in sepsis. Clin Infect Dis. 2005, 41: S459-S64. 10.1086/431997.CrossRefPubMed
35.
go back to reference Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW: Pharmacological interference with NF-κB activation attenuates central nervous system complications in experimental pneumococcal meningitis. J Infect Dis. 2000, 182: 1437-1445. 10.1086/315877.CrossRefPubMed Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW: Pharmacological interference with NF-κB activation attenuates central nervous system complications in experimental pneumococcal meningitis. J Infect Dis. 2000, 182: 1437-1445. 10.1086/315877.CrossRefPubMed
36.
go back to reference Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med. 2005, 353: 1711-1723. 10.1056/NEJMra050541.CrossRefPubMed Rhen T, Cidlowski JA: Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med. 2005, 353: 1711-1723. 10.1056/NEJMra050541.CrossRefPubMed
37.
go back to reference van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med. 2006, 354: 44-53. 10.1056/NEJMra052116.CrossRefPubMed van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med. 2006, 354: 44-53. 10.1056/NEJMra052116.CrossRefPubMed
38.
go back to reference Salluh JI, Póvoa P, Soares M, Castro-Faria-Neto HC, Bozza FA, Bozza PT: The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Crit Care. 2008, 12: R76-10.1186/cc6922.PubMedCentralCrossRefPubMed Salluh JI, Póvoa P, Soares M, Castro-Faria-Neto HC, Bozza FA, Bozza PT: The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Crit Care. 2008, 12: R76-10.1186/cc6922.PubMedCentralCrossRefPubMed
Metadata
Title
Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study
Authors
Stephen J Chapman
Chiea C Khor
Fredrik O Vannberg
Anna Rautanen
Andrew Walley
Shelley Segal
Catrin E Moore
Robert JO Davies
Nicholas P Day
Norbert Peshu
Derrick W Crook
James A Berkley
Thomas N Williams
J Anthony Scott
Adrian VS Hill
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9377

Other articles of this Issue 6/2010

Critical Care 6/2010 Go to the issue